INSIGHTS+ Insights+: The US FDA New Drug Approvals in July 2021BySenior EditorAugust 19, 20210Comments
VIEWPOINTS PharmaShots Interview: Revolo’s Jonathan Rigby Shares Insights on the ‘1104 for Eosinophilic EsophagitisBySenior EditorAugust 18, 20210Comments
VIEWPOINTS PharmaShots Interview: Janssen’s Andrew Greenspan Shares Insight About the New AGA Guidelines Recommending Stelara (Ustekinumab) as a First-Line Treatment Option in Crohn’s DiseaseBySenior EditorAugust 17, 20210Comments
VIEWPOINTS PharmaShots Interview: Adaptimmune’s Dennis Williams Shares Insight About the Company’s Pathway to Bringing the First-Ever TCR T-Cell Therapy for Solid Tumors to MarketBySenior EditorAugust 16, 20210Comments
TOP 20 Top 20 Immunology Companies Based on 2020 Immunology Segment RevenueByPrince GiriAugust 12, 20210Comments
VIEWPOINTS PharmaShots Interview: Kaia Health’s Konstantin Mehl Shares Insight on the Funding to Transform the Treatment for MSK and COPDBySenior EditorAugust 11, 20210Comments
VIEWPOINTS PharmaShots Interview: Janssen’s Jan Wehkamp Shares Insight on the Data from UNIFI Study of Stelara Presented at ECCOBySenior EditorAugust 9, 20210Comments
VIEWPOINTS PharmaShots Interview: Sanofi’s Laurent Debussche Shares Insight on the Need of SERDs for ER+ Breast CancerBySenior EditorAugust 9, 20210Comments
